Does CMV Induced Changes in NK Lymphocyte Biology Influence the Effectiveness of Antibody Therapy Used to Treat B Cell Lymphoproliferative Diseases?

NCT03417414 · clinicaltrials.gov ↗

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

B Cell Lymphocytic Leukemia
B Cell Non-Hodgkin's Lymphoma

Sponsor

Ottawa Hospital Research Institute